Biological performance and fouling mitigation in the biochar-amended anaerobic membrane bioreactor (AnMBR) treating pharmaceutical wastewater

Anaerobic membrane bioreactor (AnMBR) is an advanced technology in treating pharmaceutical wastewater, but the membrane fouling limits its development. In this study, the biochar with adsorption capacity of biopolymers was added in AnMBR to investigate its potential in treating pharmaceutical wastewater and alleviating membrane fouling. In the biochar-amended AnMBR, adsorbable organic halogen (AOX) was removed effectively, and more COD was biotransformed into CH4. Membrane fouling mitigation was achieved in the third stage with a 56% decrease of average transmembrane pressure difference (TMP) rising rate. The predominant culprit, proteins of extracellular polymeric substance (EPS-proteins) in sludge mixture and cake layer, was reduced significantly. Particularly, the proportion of micromolecular (0.1-0.15 kDa) EPS-proteins in cake layer was 1.5-folds that of the control group. The important bio-foulant genus Arcobacter aggregating on the membrane had less and almost half the relative abundance (16.5%) than that of the control group (30.7%).